Outcome and Factors Related to Isolated Liver Metastasis due to Breast Cancer
View abstract on PubMed
Summary
This summary is machine-generated.Long-term survival is achievable for breast cancer patients with liver metastasis. Developing metastasis more than three years after initial treatment is linked to better progression-free survival.
Area Of Science
- Oncology
- Surgical Oncology
- Medical Statistics
Background
- Breast cancer is a leading cause of cancer-related mortality worldwide.
- Liver metastasis significantly impacts patient prognosis and treatment strategies.
- Hepatic surgery offers a potential treatment modality for select patients with liver metastases.
Purpose Of The Study
- To identify risk factors associated with isolated liver metastasis in breast cancer patients.
- To determine prognostic factors influencing survival in these patients.
- To evaluate the outcomes of surgical intervention for breast cancer liver metastasis.
Main Methods
- Retrospective analysis of 12 breast cancer patients who underwent surgery for liver metastasis.
- Descriptive statistics for patient and metastasis characteristics.
- Kaplan-Meier method for survival analysis, with Log-rank and Cox regression tests for prognostic factor identification.
Main Results
- Out of 12 patients, 11 had recurrent disease, and one had de novo metastasis.
- Grade 3 tumors and high Ki-67 expression negatively impacted disease-free survival (DFS).
- Development of liver metastasis within 3 years of treatment correlated with worse progression-free survival (PFS) (p=0.040).
Conclusions
- Long-term survival is feasible for breast cancer patients with liver metastasis.
- The disease-free interval is a critical determinant of prognosis.
- Patients developing metastasis after three years demonstrated longer PFS.

